Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

GM Pharma International Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (367)
Cancellation by sponsor (2)

Date

2025 (8)
2024 (114)
2023 (6)
2022 (2)
2021 (6)
2020 (56)
2019 (6)
2018 (23)
2017 (19)
2016 (16)
2015 (19)
2014 (17)
2013 (16)
2012 (18)
2011 (14)
2010 (4)
2009 (13)
2007 (7)
2006 (4)
2005 (1)

Search

Sponsor content

369 result(s) found, displaying 331 to 340

BISOPROLOL-WGR bisoprolol fumarate 1.25mg tablet blister pack (182109)

13 December 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BISOPROLOL-WGR bisoprolol fumarate 1.25mg tablet blister pack.
AMISULPRIDE-WGR 400 mg tablet blister pack (178897)

3 November 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMISULPRIDE-WGR 400 mg tablet blister pack.
AMISULPRIDE-WGR 200 mg tablet blister pack (178905)

3 November 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMISULPRIDE-WGR 200 mg tablet blister pack.
AMISULPRIDE-WGR 100 mg tablet blister pack (178907)

3 November 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMISULPRIDE-WGR 100 mg tablet blister pack.
AMISULPRIDE-WGR 50 mg tablet blister pack (178893)

3 November 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMISULPRIDE-WGR 50 mg tablet blister pack.
EXEMESTANE-WGR exemestane 25 mg tablet blister pack (177313)

6 October 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for EXEMESTANE-WGR exemestane 25 mg tablet blister pack.
PIOGLITAZONE-WGR pioglitazone 15 mg (as hydrochloride) tablet blister pack (166919)

25 February 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIOGLITAZONE-WGR pioglitazone 15 mg (as hydrochloride) tablet blister pack.
PIOGLITAZONE-WGR pioglitazone 30 mg (as hydrochloride) tablet blister pack (166909)

25 February 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIOGLITAZONE-WGR pioglitazone 30 mg (as hydrochloride) tablet blister pack.
PIOGLITAZONE-WGR pioglitazone 45 mg (as hydrochloride) tablet blister pack (166912)

25 February 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIOGLITAZONE-WGR pioglitazone 45 mg (as hydrochloride) tablet blister pack.
PROCHLORPERAZINE-WGR prochlorperazine maleate 5 mg tablet blister pack (172128)

12 January 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PROCHLORPERAZINE-WGR prochlorperazine maleate 5 mg tablet blister pack.

Pages

First page
Previous page
…
Page 29
Page 30
Page 31
Page 32
Page 33
Current page 34
Page 35
Page 36
Page 37
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.